Component

Human insulin-like growth factor I / IGF1

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. IGF-I stimulated thymulin production in TEC preparations.

    Human insulin-like growth factor I / IGF1 → Thymulin Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
    experimental_contrast
    {"intervention": "igf1 exposure", "comparator": "Matched experimental control", "endpoint": "IGF-I stimulated thymulin production in TEC preparations.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    IGF-I stimulated thymulin production in TEC preparations.
    primary_references
    Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. | 1992 | DOI 10.1210/jcem.75.1.1619008 | PMID 1619008 | https://pubmed.ncbi.nlm.nih.gov/1619008/
    source_locator
    Reviewed reference lines 93-93; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 93–93

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Preparations and species as specified in statement and source; no direct iodine/selenium cofactor requirement inferred. · Recorded from source · Recorded from source

    | GH and IGF-I | Both stimulated production in TEC preparations. Blocking IGF-I or its receptor inhibited the GH response, supporting a local IGF-mediated component. The associated human endocrine observations do not isolate that mechanism in vivo. [1992 study](https://pubmed.ncbi.nlm.nih.gov/1619008/) |
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.